{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T09:09:02Z","timestamp":1778922542537,"version":"3.51.4"},"reference-count":90,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013290","name":"National Key Research and Development Program of China Stem Cell and Translational Research","doi-asserted-by":"publisher","award":["2022YFC2505100"],"award-info":[{"award-number":["2022YFC2505100"]}],"id":[{"id":"10.13039\/501100013290","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013290","name":"National Key Research and Development Program of China Stem Cell and Translational Research","doi-asserted-by":"publisher","award":["2023YFF1205101"],"award-info":[{"award-number":["2023YFF1205101"]}],"id":[{"id":"10.13039\/501100013290","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012152","name":"National Postdoctoral Program for Innovative Talents","doi-asserted-by":"publisher","award":["BX20240079"],"award-info":[{"award-number":["BX20240079"]}],"id":[{"id":"10.13039\/501100012152","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2024M760553"],"award-info":[{"award-number":["2024M760553"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["24YF2705200"],"award-info":[{"award-number":["24YF2705200"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["23JS1410200"],"award-info":[{"award-number":["23JS1410200"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["24J12800100"],"award-info":[{"award-number":["24J12800100"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U23A6010"],"award-info":[{"award-number":["U23A6010"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82403260"],"award-info":[{"award-number":["82403260"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32370978"],"award-info":[{"award-number":["32370978"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003347","name":"Fudan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.xcrm.2026.102708","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T15:18:11Z","timestamp":1774883891000},"page":"102708","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Robust transcriptomic hallmarks targeting intratumor heterogeneity in intrahepatic cholangiocarcinoma"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2914-2075","authenticated-orcid":false,"given":"Youpei","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lihua","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haichao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Penghui","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lv","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zunyun","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongbing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xupeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangze","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuyi","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junhua","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huijuan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifei","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guohe","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongning","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiancheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiren","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaoyang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liyun","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhirou","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2026.102708_bib1","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1158\/2159-8290.CD-21-1640","article-title":"Geospatial immune heterogeneity reflects the diverse tumor-immune interactions in intrahepatic cholangiocarcinoma","volume":"12","author":"Lin","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2026.102708_bib2","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202101230","article-title":"IDH mutation subgroup status associates with intratumor heterogeneity and the tumor microenvironment in intrahepatic cholangiocarcinoma","volume":"8","author":"Xiang","year":"2021","journal-title":"Adv. Sci."},{"key":"10.1016\/j.xcrm.2026.102708_bib3","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S1470-2045(20)30157-1","article-title":"Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study","volume":"21","author":"Abou-Alfa","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.xcrm.2026.102708_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1509891","article-title":"Pemigatinib combined with immunotherapy and stereotactic body radiation therapy for FGFR2 fusion-positive advanced intrahepatic cholangiocarcinoma with brain metastasis: a case report","volume":"15","author":"Guo","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.xcrm.2026.102708_bib5","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/S2468-1253(24)00095-5","article-title":"Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 study","volume":"9","author":"Oh","year":"2024","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.xcrm.2026.102708_bib6","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","article-title":"Tumour heterogeneity and resistance to cancer therapies","volume":"15","author":"Dagogo-Jack","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2026.102708_bib7","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1186\/s12967-024-05326-0","article-title":"Generalizable transcriptome-based tumor malignant level evaluation and molecular subtyping towards precision oncology","volume":"22","author":"Hu","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.xcrm.2026.102708_bib8","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ccell.2021.12.006","article-title":"Proteogenomic characterization identifies clinically relevant subgroups of intrahepatic cholangiocarcinoma","volume":"40","author":"Dong","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2026.102708_bib9","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1002\/hep.25890","article-title":"Transcriptomic profiling reveals hepatic stem-like gene signatures and interplay of miR-200c and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma","volume":"56","author":"Oishi","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.xcrm.2026.102708_bib10","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/ng.3375","article-title":"Genomic spectra of biliary tract cancer","volume":"47","author":"Nakamura","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.xcrm.2026.102708_bib11","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1053\/j.gastro.2013.01.001","article-title":"Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes","volume":"144","author":"Sia","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.xcrm.2026.102708_bib12","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1053\/j.gastro.2011.12.005","article-title":"Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors","volume":"142","author":"Andersen","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.xcrm.2026.102708_bib13","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/hep.31092","article-title":"Identification of four immune subtypes characterized by distinct composition and functions of tumor microenvironment in intrahepatic cholangiocarcinoma","volume":"72","author":"Job","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.xcrm.2026.102708_bib14","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/gutjnl-2021-326514","article-title":"Novel microenvironment-based classification of intrahepatic cholangiocarcinoma with therapeutic implications","volume":"72","author":"Martin-Serrano","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.xcrm.2026.102708_bib15","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-004892","article-title":"Multimodule characterization of immune subgroups in intrahepatic cholangiocarcinoma reveals distinct therapeutic vulnerabilities","volume":"10","author":"Lin","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.xcrm.2026.102708_bib16","doi-asserted-by":"crossref","first-page":"5362","DOI":"10.1158\/1078-0432.CCR-15-2889","article-title":"Intratumor heterogeneity affects gene expression profile test prognostic risk stratification in early breast cancer","volume":"22","author":"Gyanchandani","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2026.102708_bib17","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/s41379-018-0029-3","article-title":"Multiregion gene expression profiling reveals heterogeneity in molecular subtypes and immunotherapy response signatures in lung cancer","volume":"31","author":"Lee","year":"2018","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.xcrm.2026.102708_bib18","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst."},{"key":"10.1016\/j.xcrm.2026.102708_bib19","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1038\/s41591-019-0595-z","article-title":"A clonal expression biomarker associates with lung cancer mortality","volume":"25","author":"Biswas","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2026.102708_bib20","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1038\/s41467-022-29164-0","article-title":"Single-cell transcriptomic analysis suggests two molecularly subtypes of intrahepatic cholangiocarcinoma","volume":"13","author":"Song","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102708_bib21","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41586-022-05400-x","article-title":"Liver tumour immune microenvironment subtypes and neutrophil heterogeneity","volume":"612","author":"Xue","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102708_bib22","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.jhep.2021.06.028","article-title":"Single-cell atlas of tumor cell evolution in response to therapy in hepatocellular carcinoma and intrahepatic cholangiocarcinoma","volume":"75","author":"Ma","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.xcrm.2026.102708_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.24107","article-title":"Developing metabolic gene signatures to predict intrahepatic cholangiocarcinoma prognosis and mining a miRNA regulatory network","volume":"36","author":"Ran","year":"2022","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.xcrm.2026.102708_bib24","article-title":"Development of a prognostic signature based on single-cell RNA sequencing data of immune cells in intrahepatic cholangiocarcinoma","volume":"11","author":"Su","year":"2020","journal-title":"Front. Genet."},{"key":"10.1016\/j.xcrm.2026.102708_bib25","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/17474124.2022.2029700","article-title":"Identification of a ferroptosis-related gene signature for predicting the prognosis of cholangiocarcinoma","volume":"16","author":"Wang","year":"2022","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.xcrm.2026.102708_bib26","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1186\/s12935-021-02310-2","article-title":"PIWIL4 and SUPT5H combine to predict prognosis and immune landscape in intrahepatic cholangiocarcinoma","volume":"21","author":"Zou","year":"2021","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.xcrm.2026.102708_bib27","doi-asserted-by":"crossref","first-page":"869","DOI":"10.7150\/ijbs.38846","article-title":"Prognostic values of a novel multi-mRNA signature for predicting relapse of cholangiocarcinoma","volume":"16","author":"Guo","year":"2020","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.xcrm.2026.102708_bib28","first-page":"1204","article-title":"Immune infiltration and a ferroptosis-related gene signature for predicting the prognosis of patients with cholangiocarcinoma","volume":"14","author":"Wang","year":"2022","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.xcrm.2026.102708_bib29","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1002\/hep.31803","article-title":"A transcriptomic signature for risk-stratification and recurrence prediction in intrahepatic cholangiocarcinoma","volume":"74","author":"Wada","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.xcrm.2026.102708_bib30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41568-018-0081-9","article-title":"The lung microenvironment: an important regulator of tumour growth and metastasis","volume":"19","author":"Altorki","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.xcrm.2026.102708_bib31","doi-asserted-by":"crossref","first-page":"9280","DOI":"10.18632\/aging.102332","article-title":"Loss of FoxA2 accelerates neoplastic changes in the intrahepatic bile duct partly via the MAPK signaling pathway","volume":"11","author":"Shen","year":"2019","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.xcrm.2026.102708_bib32","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1093\/glycob\/cwz098","article-title":"The O-GalNAcylating enzyme GALNT5 mediates carcinogenesis and progression of cholangiocarcinoma via activation of AKT\/ERK signaling","volume":"30","author":"Detarya","year":"2020","journal-title":"Glycobiology"},{"key":"10.1016\/j.xcrm.2026.102708_bib33","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/cac2.12513","article-title":"Multiomics analysis reveals metabolic subtypes and identifies diacylglycerol kinase \u03b1 (DGKA) as a potential therapeutic target for intrahepatic cholangiocarcinoma","volume":"44","author":"Liu","year":"2024","journal-title":"Cancer Commun."},{"key":"10.1016\/j.xcrm.2026.102708_bib34","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/hep.32624","article-title":"Proteogenomic characterization of cholangiocarcinoma","volume":"77","author":"Deng","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.xcrm.2026.102708_bib35","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1158\/2159-8290.CD-17-0368","article-title":"Whole-genome and epigenomic landscapes of etiologically distinct subtypes of cholangiocarcinoma","volume":"7","author":"Jusakul","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2026.102708_bib36","doi-asserted-by":"crossref","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","article-title":"TIMER2.0 for analysis of tumor-infiltrating immune cells","volume":"48","author":"Li","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2026.102708_bib37","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40425-017-0215-8","article-title":"Gene expression markers of tumor infiltrating leukocytes","volume":"5","author":"Danaher","year":"2017","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.xcrm.2026.102708_bib38","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1146\/annurev-immunol-032713-120145","article-title":"Chemokines and chemokine receptors: positioning cells for host defense and immunity","volume":"32","author":"Griffith","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2026.102708_bib39","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nri.2017.49","article-title":"Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy","volume":"17","author":"Nagarsheth","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2026.102708_bib40","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/carcin\/bgt397","article-title":"CXCL5 contributes to tumor metastasis and recurrence of intrahepatic cholangiocarcinoma by recruiting infiltrative intratumoral neutrophils","volume":"35","author":"Zhou","year":"2014","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.xcrm.2026.102708_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015543","article-title":"Nearest template prediction: a single-sample-based flexible class prediction with confidence assessment","volume":"5","author":"Hoshida","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2026.102708_bib42","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adg3358","article-title":"Pharmaco-proteogenomic characterization of liver cancer organoids for precision oncology","volume":"15","author":"Ji","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2026.102708_bib43","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.2147\/JHC.S437415","article-title":"Predicting T cell-inflamed gene expression profile in hepatocellular carcinoma based on dynamic contrast-enhanced ultrasound radiomics","volume":"10","author":"Wang","year":"2023","journal-title":"J. Hepatocell. Carcinoma"},{"key":"10.1016\/j.xcrm.2026.102708_bib44","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1172\/JCI91190","article-title":"IFN-\u03b3-related mRNA profile predicts clinical response to PD-1 blockade","volume":"127","author":"Ayers","year":"2017","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.xcrm.2026.102708_bib45","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/s41416-020-01145-4","article-title":"A balance score between immune stimulatory and suppressive microenvironments identifies mediators of tumour immunity and predicts pan-cancer survival","volume":"124","author":"Turan","year":"2021","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.xcrm.2026.102708_bib46","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","article-title":"Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response","volume":"24","author":"Jiang","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2026.102708_bib47","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.csbj.2023.12.001","article-title":"Inflammatory response signature score model for predicting immunotherapy response and pan-cancer prognosis","volume":"23","author":"Chen","year":"2024","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.xcrm.2026.102708_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.758288","article-title":"Single-cell transcriptomic analysis reveals a tumor-reactive T cell signature associated with clinical outcome and immunotherapy response in melanoma","volume":"12","author":"Yan","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2026.102708_bib49","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cell.2016.02.065","article-title":"Genomic and transcriptomic features of response to anti-PD-1 therapy in metastatic melanoma","volume":"165","author":"Hugo","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102708_bib50","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1038\/s41591-018-0157-9","article-title":"Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma","volume":"24","author":"Auslander","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2026.102708_bib51","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41525-021-00169-w","article-title":"Ratio of the interferon-\u03b3 signature to the immunosuppression signature predicts anti-PD-1 therapy response in melanoma","volume":"6","author":"Cui","year":"2021","journal-title":"npj Genom. Med."},{"key":"10.1016\/j.xcrm.2026.102708_bib52","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1158\/0008-5472.CAN-14-2005","article-title":"Lung tumor suppressor GPRC5A binds EGFR and restrains its effector signaling","volume":"75","author":"Zhong","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2026.102708_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217067","article-title":"GPRC5A promotes gallbladder cancer metastasis by upregulating TNS4 via the JAK2-STAT3 pathway","volume":"598","author":"Yang","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.xcrm.2026.102708_bib54","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1097\/PAS.0000000000002224","article-title":"An immunohistochemical analysis of osteopontin and S100 calcium-binding protein P is useful for subclassifying large- and small-duct type intrahepatic cholangiocarcinomas","volume":"48","author":"Yoshizawa","year":"2024","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.xcrm.2026.102708_bib55","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/4946197","article-title":"Downregulation of FXYD2 is associated with poor prognosis and increased regulatory T cell infiltration in clear cell renal cell carcinoma","volume":"2022","author":"Zhang","year":"2022","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.xcrm.2026.102708_bib56","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41591-021-01233-9","article-title":"Intratumoral heterogeneity in cancer progression and response to immunotherapy","volume":"27","author":"Vitale","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2026.102708_bib57","doi-asserted-by":"crossref","first-page":"5361","DOI":"10.1038\/s41467-018-07767-w","article-title":"Local mutational diversity drives intratumoral immune heterogeneity in non-small cell lung cancer","volume":"9","author":"Jia","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102708_bib58","doi-asserted-by":"crossref","first-page":"5577","DOI":"10.1016\/j.cell.2021.09.022","article-title":"Spatially confined sub-tumor microenvironments in pancreatic cancer","volume":"184","author":"Gr\u00fcnwald","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102708_bib59","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1158\/0008-5472.CAN-21-3917","article-title":"HSP90 mediates IFN\u03b3-induced adaptive resistance to anti-PD-1 immunotherapy","volume":"82","author":"Liu","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2026.102708_bib60","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/s41467-017-00449-z","article-title":"HSP90 inhibition enhances cancer immunotherapy by upregulating interferon response genes","volume":"8","author":"Mbofung","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102708_bib61","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.cstres.2024.08.002","article-title":"Previously unrecognized and potentially consequential challenges facing Hsp90 inhibitors in cancer clinical trials","volume":"29","author":"Chang","year":"2024","journal-title":"Cell Stress Chaperones"},{"key":"10.1016\/j.xcrm.2026.102708_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176387","article-title":"HSP90: A promising target for NSCLC treatments","volume":"967","author":"Zhu","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.xcrm.2026.102708_bib63","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/S1470-2045(25)00376-6","article-title":"Conversion therapy of tislelizumab plus lenvatinib and GEMOX in unresectable locally advanced biliary tract cancer (ZSAB-TransGOLP): a multicentre, prospective, phase 2 study","volume":"26","author":"Shi","year":"2025","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.xcrm.2026.102708_bib64","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41392-023-01317-7","article-title":"Toripalimab combined with lenvatinib and GEMOX is a promising regimen as first-line treatment for advanced intrahepatic cholangiocarcinoma: a single-center, single-arm, phase 2 study","volume":"8","author":"Shi","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.xcrm.2026.102708_bib65","doi-asserted-by":"crossref","first-page":"4713","DOI":"10.1016\/j.cell.2024.06.012","article-title":"Progestogen-driven B7-H4 contributes to onco-fetal immune tolerance","volume":"187","author":"Yu","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102708_bib66","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1038\/s41467-023-36881-7","article-title":"mTORC1 upregulates B7-H3\/CD276 to inhibit antitumor T cells and drive tumor immune evasion","volume":"14","author":"Liu","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102708_bib67","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202400757","article-title":"Tuning immune-cold tumor by suppressing USP10\/B7-H4 proteolytic axis reinvigorates therapeutic efficacy of ADCs","volume":"11","author":"Zeng","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.xcrm.2026.102708_bib68","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1158\/1535-7163.MCT-22-0786","article-title":"Discovery and preclinical characterization of XMT-1660, an optimized B7-H4-targeted antibody-drug conjugate for the treatment of cancer","volume":"22","author":"Toader","year":"2023","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.xcrm.2026.102708_bib69","doi-asserted-by":"crossref","first-page":"3848","DOI":"10.1158\/0008-5472.CAN-23-4099","article-title":"A dual-payload antibody-drug conjugate targeting CD276\/B7-H3 elicits cytotoxicity and immune activation in triple-negative breast cancer","volume":"84","author":"Zhou","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2026.102708_bib70","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1158\/1078-0432.CCR-25-0884","article-title":"Combined targeting of PD-1 and TIM-3 in patients with locally advanced or metastatic melanoma: AMBER Cohorts 1c, 1e, and 2A","volume":"31","author":"Davar","year":"2025","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2026.102708_bib71","doi-asserted-by":"crossref","first-page":"9950","DOI":"10.1038\/s41467-024-54251-9","article-title":"GPRC5A promotes lung colonization of esophageal squamous cell carcinoma","volume":"15","author":"Zhou","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102708_bib72","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1139\/bcb-2022-0352","article-title":"The G protein-coupled receptor GPRC5A-a phorbol ester and retinoic acid-induced orphan receptor with roles in cancer, inflammation, and immunity","volume":"101","author":"Iglesias Gonz\u00e1lez","year":"2023","journal-title":"Biochem. Cell. Biol."},{"key":"10.1016\/j.xcrm.2026.102708_bib73","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3892\/or.2016.4807","article-title":"Aberrant expression of B7-H4 correlates with poor prognosis and suppresses tumor-infiltration of CD8+ T lymphocytes in human cholangiocarcinoma","volume":"36","author":"Zhao","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.xcrm.2026.102708_bib74","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1038\/s41419-017-0015-6","article-title":"Upregulation of B7-H4 promotes tumor progression of intrahepatic cholangiocarcinoma","volume":"8","author":"Xie","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.xcrm.2026.102708_bib75","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102708_bib76","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkw520","article-title":"FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing","volume":"44","author":"Shen","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2026.102708_bib77","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1093\/bioinformatics\/bty304","article-title":"AnnotSV: an integrated tool for structural variations annotation","volume":"34","author":"Geoffroy","year":"2018","journal-title":"Bioinformatics"},{"key":"10.1016\/j.xcrm.2026.102708_bib78","doi-asserted-by":"crossref","first-page":"R41","DOI":"10.1186\/gb-2011-12-4-r41","article-title":"GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers","volume":"12","author":"Mermel","year":"2011","journal-title":"Genome Biol."},{"key":"10.1016\/j.xcrm.2026.102708_bib79","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17204-5","article-title":"QuPath: Open source software for digital pathology image analysis","volume":"7","author":"Bankhead","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2026.102708_bib80","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1158\/2159-8290.CD-21-1077","article-title":"Mutant IDH inhibits IFN\u03b3-TET2 signaling to promote immunoevasion and tumor maintenance in cholangiocarcinoma","volume":"12","author":"Wu","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2026.102708_bib81","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cell.2014.12.033","article-title":"Molecular and genetic properties of tumors associated with local immune cytolytic activity","volume":"160","author":"Rooney","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102708_bib82","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaf8399","article-title":"Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy","volume":"355","author":"Davoli","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2026.102708_bib83","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.26476","article-title":"Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data","volume":"6","author":"Racle","year":"2017","journal-title":"eLife"},{"key":"10.1016\/j.xcrm.2026.102708_bib84","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13059-016-1028-7","article-title":"Comprehensive analyses of tumor immunity: implications for cancer immunotherapy","volume":"17","author":"Li","year":"2016","journal-title":"Genome Biol."},{"key":"10.1016\/j.xcrm.2026.102708_bib85","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jhep.2019.09.032","article-title":"Reliability of a single-region sample to evaluate tumor immune microenvironment in hepatocellular carcinoma","volume":"72","author":"Shen","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.xcrm.2026.102708_bib86","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","article-title":"Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade","volume":"18","author":"Charoentong","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2026.102708_bib87","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.immuni.2013.10.003","article-title":"Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer","volume":"39","author":"Bindea","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2026.102708_bib88","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1186\/s13046-018-1002-1","article-title":"Classification of triple-negative breast cancers based on immunogenomic profiling","volume":"37","author":"He","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2026.102708_bib89","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"key":"10.1016\/j.xcrm.2026.102708_bib90","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.lungcan.2013.07.016","article-title":"Evaluation of EGFR protein expression by immunohistochemistry using H-score and the magnification rule: re-analysis of the SATURN study","volume":"82","author":"Mazi\u00e8res","year":"2013","journal-title":"Lung Cancer"}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126001254?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126001254?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T08:20:38Z","timestamp":1778919638000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379126001254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":90,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2666379126001254"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102708","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Robust transcriptomic hallmarks targeting intratumor heterogeneity in intrahepatic cholangiocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102708","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102708"}}